Dec 3rd 2013, 19:01, by Russell Brandom
It’s been a week since the FDA brought the hammer down on personal genetics service 23andMe, and for followers of the company, the future is still uncertain. According to the order, the company has 15 business days (now 11 and counting) to offer the FDA a compliance plan, which is then open for comment from the agency. It’s still unclear if the end result will allow the company to continue selling its $99 saliva test kits, but the ramifications are already being felt. 23andMe announced yesterday that it was ending its marketing campaigns, but it’s likely just the first step in the process. The FDA, for its part, is staying quiet. The agency declined to comment, except to say that the 15-day grace period is standard and the...
Continue reading…
No comments:
Post a Comment